Precision DNA editing gene therapy achieves deep remissions in aggressive leukemia previously considered incurable.

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell ...

Consensus Project Task Force recently published a report of their refined approach in the journal, Transplantation and ...

The Pediatric Stem Cell Transplant Program performs approximately 130 transplants annually for patients from birth to under 14 years of age, following internationally accredited clinical and quality ...

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem-cell-based therapy to treat severe aplastic anemia (SAA). The approval, which comes more than two years after Omisirge ...

A group of siblings who had not seen their beloved grandpa for nearly a year because of his stem cell transplant sprinted through their garden with delight when they realized he had crossed the ...

Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.